Aktieanalys

Coala Life Q4 2022 initial take: Optimistic outlook - Redeye

Redeye Publicerad: 31 Mar 2023 10:25

Redeye comments on Coala Life’s Q4’22 report, in which sales increased by c80% over the previous quarter. OPEX was impacted by one-time expenditures, primarily related to regulatory concerns but also resulting from Coala's extended offer in the United States. Given the indication of product-market fit in the US, with a reported ARR of USD4.6m for February '23, we anticipate a fast commercial ramp-up throughout '23. With the recent equity issue dilution as a backdrop, we expect our Base Case (SEK14) to be reduced by a least 75%.

Länk till analysen i sin helhet: https://www.redeye.se/research/891809/coala-life-q4-2022-initial-take-optimistic-outlook?utm_source=finwire&utm_medium=RSS

Nyheter om Coala-life

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!